Search for: "Tom Lamb"
Results 781 - 800
of 1,047
Sorted by Relevance
|
Sort by Date
5 Oct 2021, 1:23 pm
(Case review is done by attorney Tom Lamb) [read post]
1 Nov 2016, 12:53 pm
(Case review done by attorney Tom Lamb) [read post]
14 Dec 2010, 11:35 am
It was two days since I gave Biscuit the left over leg of lamb -- could this be the consequence of my indulging her thusly? [read post]
16 Oct 2007, 1:57 pm
Events Leading Up To October 2007 FDA Recall Include A Little Noticed March 2007 "Dear Doctor" Letter And July 2007 Medical Journal Article About Model 6949 (Posted by Tom Lamb at DrugInjuryWatch.com) An October 16, 2007 article in The Wall Street Journal about the Fidelis Sprint leads recall presented the current situation:In announcing the recall early yesterday, Medtronic said that its Sprint Fidelis leads have broken at a rate apparently higher than that… [read post]
31 Oct 2008, 3:34 pm
I happened to read Tom Lamb’s article (Drug Injury Watch) this morning about Avandia. [read post]
13 Mar 2008, 1:15 pm
Opinion: Patient Lawsuits Are A Significant Incentive For These Manufacturers And Companies To Ensure That Their Products Are Safe For Use By American Patients (Posted by Tom Lamb at DrugInjuryWatch.com) First of all, I presume most of you believe - because as Americans we have always looked to our court system to vindicate our rights - that we are allowed to file these lawsuits today. [read post]
12 Sep 2024, 1:40 pm
August 2024 Veozah Drug Label Change Adds Warnings About Liver Toxicity and Abnormal Liver Tests (Posted by Tom Lamb at Drug Injury Watch) On September 12, 2024, the FDA announced a warning about the rare occurrence of serious liver injury when a woman is using Veozah for hot flashes due to menopause. [read post]
11 Mar 2013, 11:30 am
December 31, 2012 Totals: 2,075 New Jersey (NJ) State Court Lawsuits, With 820 Cases Pending In Federal Court Fosamax MDL And 420 California Claims (Posted by Tom Lamb at DrugInjuryWatch.com)The first Fosamax - femur fracture trial, Su v. [read post]
15 Nov 2012, 2:00 pm
The Relatively New Diabetes Medication Victoza From Novo Nordisk Was Only Approved By FDA In 2010 (Posted by Tom Lamb at DrugInjuryWatch.com) In November 2012 The Annals of Pharmacotherapy published online before print this new medical journal article about Victoza, "Pancreatitis: A Potential Complication of Liraglutide? [read post]
27 Feb 2018, 9:12 am
(Case review done by attorney Tom Lamb) [read post]
4 May 2016, 1:40 pm
(Case review done by attorney Tom Lamb) [read post]
21 Feb 2019, 2:00 pm
(Case review done by attorney Tom Lamb) [read post]
18 Jul 2023, 11:45 am
(Attorney Tom Lamb does all case reviews) [read post]
18 Apr 2022, 12:15 pm
(Case review is done by attorney Tom Lamb) [read post]
31 Mar 2016, 6:40 am
(Case review done by attorney Tom Lamb) [read post]
23 Feb 2022, 12:45 pm
(Case review is done by attorney Tom Lamb) [read post]
31 Mar 2017, 1:50 pm
March 2017 FDA Report Provides Update On Emerging Safety Issue: Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) (Posted by Tom Lamb at DrugInjuryWatch.com) In March 2017 the FDA updated its "Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)" information page (accessed 3/31/17). [read post]
12 Dec 2024, 3:05 pm
New Cases of Liver Transplants And Liver-Related Deaths Among Patients Who Did Not Have Cirrhosis (Posted by Tom Lamb at Drug Injury Watch) In a December 12, 2024, Drug Safety Communication the FDA said it had recently found cases of Ocaliva liver injury among patients who did not yet have cirrhosis, or scarring of the liver, including reports of liver transplants and liver-related deaths. [read post]
30 Sep 2024, 11:02 am
Federal Appeals Court Rejects Merck's Legal Defense of Federal Preemption in September 2024 (Posted by Tom Lamb at Drug Injury Watch) A federal appeals court ruled in September 2024 that more than 500 plaintiffs should have their Fosamax femur fracture drug injury lawsuits reinstated and sent back to the current judge presiding over the federal court Fosamax MDL litigation. [read post]
4 Apr 2024, 11:52 am
Retinal Vasculitis After Syfovre Injections: Etiology is Still Unknown and Incidence Rate Remains Unclear (Posted by Tom Lamb at Drug Injury Watch) Syfovre (pegcetacoplan) was approved by the FDA in February 2023 as an eye injection to treat geographic atrophy (GA), a relatively rare condition secondary to age-related macular degeneration. [read post]
